8 November 2024 - Healthcare solutions company Johnson & Johnson (NYSE: JNJ) announced on Friday that it has submitted applications to the US FDA and European Medicines Agency for approval of DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) a...
8 November 2024 - Castle Biosciences Inc (Nasdaq: CSTL), a provider of diagnostic testing for skin cancers and other conditions, announced on Friday that it will present new data on its DecisionDx-Melanoma and MyPath Melanoma tests at the American So...
8 November 2024 - Bruker Corporation (Nasdaq: BRKR), a provider of scientific instruments and high value analytical and diagnostic solutions, on Friday announced EpicIF, an innovative fluorescence signal removal technology that significantly enhances...
8 November 2024 - IceCure Medical Ltd (Nasdaq: ICCM), a developer of minimally-invasive cryoablation technology, announced on Friday that it received a positive vote from the FDA's Medical Device Advisory Committee Panel, with 9 out of 14 paneli...
8 November 2024 - Biopharmaceutical company Dizal (SSE:688192) announced on Friday that it has submitted a New Drug Application (NDA) to the US FDA for sunvozertinib, targeting locally advanced or metastatic non-small cell lung cancer (NSCLC) with EG...